Stantec's Backlog Is Screaming Buy Signal — Is the Market Listening?

# Stantec's Backlog Is Screaming Buy Signal — Is the Market Listening?

Here's a stock that just posted record margins, raised guidance, doubled its buyback authorization, and stacked a backlog to an all-time high — and yet the tape still seems to be arguing with the fundamentals. That's the tension at the heart of Stantec (STN) right now, and it's exactly the kind of setup that makes this desk pay attention.

Let's start with what actually happened, because it's genuinely good. On August 12, Stantec dropped Q2 2026 numbers that checked every box a bull could ask for: net revenue of $1.8 billion, up 11.5% year-over-year, powered by 7.1% organic growth — the kind of number that tells you this isn't just acquisitions doing the heavy lifting. Adjusted EBITDA jumped 17.1% to $332.9 million, and the margin hit a record 18.7%. Not "good for the sector." Record. Full stop.

And management didn't just print a good quarter and go quiet — they raised full-year adjusted EBITDA guidance, with FY2026 adjusted EPS now guided to $4.37–$4.49. That's a company telling you it sees momentum building into the back half of the year, not fading.

Then there's the backlog, which is really the whole thesis in one number. Stantec closed Q1 2026 with a record C$9.0 billion in backlog, and by the time Q2 numbers rolled in, that figure had reportedly pushed to C$9.2 billion. In a services business, backlog is destiny — it's revenue visibility you can actually underwrite, not a hope. Nine-plus billion Canadian dollars of contracted work is a long runway, and it's why the bull case here isn't speculative — it's arithmetic.

Management put its money where its mouth is too. On August 18, the TSX approved an amendment to Stantec's buyback program that more than doubled its repurchase capacity — from roughly 2.28 million shares to 5.70 million. That's not a token gesture. That's a board signaling it thinks the stock is cheap enough, and the balance sheet is strong enough, to be aggressive about shrinking the float.

So where's the catch? A few places worth taking seriously.

First, valuation. STN has historically traded at a premium to engineering and consulting peers, and premiums only survive as long as the growth story keeps delivering. If organic growth or margin expansion so much as stumbles, that multiple compresses fast — that's just how re-rating works in both directions.

Second, management has explicitly flagged appetite for more M&A over the next 12 months. That's a double-edged signal. Accretive tuck-ins have clearly worked for Stantec before, but "higher transaction activity" is also code for integration risk and the possibility of paying up in a competitive deal market. Watch the price discipline here.

Third — and this is the more interesting wrinkle — some of our internal read on this name still shows technical scars from earlier in the year: a stock that traded well off its highs, a 52-week range stretching down toward the mid-$60s, cash flow softness flagged around Q1, and a forward multiple that looked genuinely discounted relative to the operating story. If that technical weakness persists even after a quarter this strong, it tells you the market hasn't fully digested the re-rate yet — which, depending on your view, is either a red flag or the entry point value investors dream about.

Our house lean: this is a name where the fundamentals are outrunning the market's willingness to pay up for them. Record margins, record backlog, raised guidance, and a management team buying back stock aggressively — that's not a company managing decline, that's a company compounding. The risks are real (M&A execution, infrastructure spending cycles, FX exposure as a Canadian domiciled global operator) but they're the ordinary risks of a growth story, not the warning signs of one breaking down.

Q3 earnings should land around mid-November, and that print — plus how disciplined the buyback pace looks between now and then — will tell us whether the market finally catches up to the story Stantec has been telling all year. Until then, the backlog does the talking, and right now it's saying more than the stock chart is.